Recapitulation of clinical and molecular hallmarks of lipid-induced hepatic insulin resistance in a zonated, vascularized human liver acinus microphysiological system during metabolic dysfunction-associated steatotic liver disease (MASLD) progression
Julio Aleman, Lawrence Vernetti, Mark E Schurdak, Richard DeBiasio, Greg LaRocca, Vijay K Yechoor, D Lansing Taylor, Andrew M Stern, Mark T Miedel · 2026
Read Recapitulation of clinical and molecular hallmarks of lipid-induced hepatic insulin resistance in a zonated, vascularized human liver acinus microphysiological system during metabolic dysfunction-associated steatotic liver disease (MASLD) progression by Julio Aleman, Lawrence Vernetti, Mark E Schurdak, Richard DeBiasio, Greg LaRocca, Vijay K Yechoor, D Lansing Taylor, Andrew M Stern, Mark T Miedel (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13217926.txt.
Description
Aleman and co-authors refine a lab-grown human liver system to model fatty liver disease and its stages. The disease affects about 30 percent of people worldwide and varies a lot by genes and lifestyle. That spread makes new drugs hard to develop and test.
Their system, called vLAMPS, builds a small, zoned liver unit with blood-vessel-like flow. By changing the fluids fed to it, the team copied normal function and each disease stage. They saw fat-driven insulin resistance, star cell activation, and scarring. The setup gives drug makers an all-human test bed.
Catalog record
| CREATOR | Julio Aleman, Lawrence Vernetti, Mark E Schurdak, Richard DeBiasio, Greg LaRocca, Vijay K Yechoor, D Lansing Taylor, Andrew M Stern, Mark T Miedel |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 57 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |